Hamilton Thorne Ltd. (0ZM.F)
| Previous close | 0.9050 |
| Open | 0.9100 |
| Bid | 0.9150 x 0 |
| Ask | 0.9550 x 0 |
| Day's range | 0.9100 - 0.9100 |
| 52-week range | 0.7350 - 1.1400 |
| Volume | |
| Avg. volume | 9 |
| Market cap | 144.962M |
| Beta (5Y monthly) | 0.29 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0000 |
| Earnings date | 13 May 2024 - 17 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Hamilton Thorne Ltd.'s (TSE:HTL) largest shareholders are retail investors with 51% ownership, institutions own 33%
Key Insights Hamilton Thorne's significant retail investors ownership suggests that the key decisions are influenced by...
GlobeNewswireHamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2023
Revenue of $67.2 million for the year and $18.4 million for the 4th quarter; Adj. EBITDA of $11.5 million for the year and $3.7 million for the quarterBEVERLY, Mass. and TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the fourth quarter an
- GlobeNewswire
Hamilton Thorne to Announce Q4 and Full Year 2023 Financial Results and Hold Conference Call on March 27, 2024
BEVERLY, Mass. and TORONTO, March 21, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three and twelve months ended December 31, 2023 before market open on Wednesday, March 27, 2024. The press release, with accompanying financial inform
